Initiation of Insulin Glargine Therapy in Type 2 Diabetes Subjects Sub-optimally Controlled on Oral Antidiabetic Agents: Results From The At. Lantus Trial
posted on 2008-05-19, 09:16authored byMelanie J. Davies, Fernando Lavelle-Gonzalez, Fred Storms, Ramon Gomis
Initiation of Insulin Glargine Therapy in Type 2 Diabetes Subjects Sub-optimally Controlled on Oral Antidiabetic Agents: Results From The At. Lantus Trial
This is the author's final draft of the version published as Diabetes Obesity & Metabolism, 10 (5), pp.387-399. This can be accessed online at http://www.blackwell-synergy.com/doi/abs/10.1111/j.1463-1326.2008.00873.x